This Center grant requests funding for six core facilities; Administrative, Clinical/Translational, Cellular Imaging, Mouse Neurodevelopmental Behavior, Mouse Gene Manipulation and Molecular Genetics, to support a broadly-based research program in intellectual and developmental disabilities at Boston Children's Hospital and Harvard Medical School.
Our specific aims are to: 1) Maintain and introduce new ?state of the art? core facilities that can be shared by Intellectual and Developmental Disabilities Research Center (IDDRC) investigators, providing core research services not possible in a single laboratory; 2) Use the framework of the core laboratories to enhance and encourage collaboration between IDDRC investigators; 3) Provide core services to aid in the training of young investigators and trainees and 4) Use the core services provided by the IDDRC program to leverage collaboration outside the institution, particularly with other IDDRCs, to speed the development of effective clinical interventions in intellectual and developmental disabilities. The Center supports 105 research projects and 64 investigators who receive approximately $71M in external funding, $46M of which is from the NIH. Research in the Center occurs in over 125,000 sq.ft. of space in research buildings at Boston Children's Hospital and Harvard Medical School affiliated institutions in the Harvard Longwood Medical Area. Our research focuses on three programmatic areas- Basic Neuroscience, Clinical / Translational Neuroscience and Genetics- and our primary goal is to identify the causes of and develop therapies for children with intellectual and developmental disabilities. The research of this IDDRC encompasses laboratory research on fundamental processes of normal and abnormal neurodevelopment and plasticity, as well as clinical and behavioral studies directed at disorders including, but not limited to, autistic spectrum disorders, brain injury, neuro-oncology, learning and cognitive disabilities, the effects of surgery and environmental toxins on neural development, and multiple neurogenetic disorders, including those that affect neural formation, migration, specification and synaptic connectivity, as well as muscular dystrophy.

Public Health Relevance

The goals of this IDDRC are threefold; support outstanding research into the causes of Intellectual and developmental disorders, train the next generation of researchers in this field, and finally develop new therapies for children with these disabilities. Ultimately, these goals are directed toward improving the quality of life of children with IDD, to enable them to achieve their maximal potential as adults.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54HD090255-01
Application #
9229196
Study Section
Special Emphasis Panel (ZHD1-DSR-H (50))
Program Officer
Parisi, Melissa
Project Start
2016-09-23
Project End
2021-05-31
Budget Start
2016-09-23
Budget End
2017-05-31
Support Year
1
Fiscal Year
2016
Total Cost
$1,008,532
Indirect Cost
$438,740
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Torres, Alcy; Brownstein, Catherine A; Tembulkar, Sahil K et al. (2018) De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome. Mol Genet Metab Rep 16:23-29
Shannon, Morgan L; Fame, Ryann M; Chau, Kevin F et al. (2018) Mice Expressing Myc in Neural Precursors Develop Choroid Plexus and Ciliary Body Tumors. Am J Pathol 188:1334-1344
Liang, Liang; Fratzl, Alex; Goldey, Glenn et al. (2018) A Fine-Scale Functional Logic to Convergence from Retina to Thalamus. Cell 173:1343-1355.e24
Chau, Kevin F; Shannon, Morgan L; Fame, Ryann M et al. (2018) Downregulation of ribosome biogenesis during early forebrain development. Elife 7:
O'Leary, Heather M; Kaufmann, Walter E; Barnes, Katherine V et al. (2018) Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol 5:323-332
Waszak, Sebastian M; Northcott, Paul A; Buchhalter, Ivo et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785-798
Lundgren, Pia; Hård, Anna-Lena; Wilde, Åsa et al. (2018) Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity. Acta Paediatr 107:767-773
Guo, Nannan; Soden, Marta E; Herber, Charlotte et al. (2018) Dentate granule cell recruitment of feedforward inhibition governs engram maintenance and remote memory generalization. Nat Med 24:438-449
Wells, Elizabeth M; Ullrich, Nicole J; Seidel, Kristy et al. (2018) Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report. Neuro Oncol 20:132-142
Sacharow, Stephanie J; Dudenhausen, Elizabeth E; Lomelino, Carrie L et al. (2018) Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency. Mol Genet Metab 123:317-325

Showing the most recent 10 out of 498 publications